Macrophages, Low-Grade Inflammation, Insulin Resistance and Hyperinsulinemia: A Mutual Ambiguous Relationship in the Development of Metabolic Diseases
Overview
Affiliations
Metabolic derangement with poor glycemic control accompanying overweight and obesity is associated with chronic low-grade inflammation and hyperinsulinemia. Macrophages, which present a very heterogeneous population of cells, play a key role in the maintenance of normal tissue homeostasis, but functional alterations in the resident macrophage pool as well as newly recruited monocyte-derived macrophages are important drivers in the development of low-grade inflammation. While metabolic dysfunction, insulin resistance and tissue damage may trigger or advance pro-inflammatory responses in macrophages, the inflammation itself contributes to the development of insulin resistance and the resulting hyperinsulinemia. Macrophages express insulin receptors whose downstream signaling networks share a number of knots with the signaling pathways of pattern recognition and cytokine receptors, which shape macrophage polarity. The shared knots allow insulin to enhance or attenuate both pro-inflammatory and anti-inflammatory macrophage responses. This supposedly physiological function may be impaired by hyperinsulinemia or insulin resistance in macrophages. This review discusses the mutual ambiguous relationship of low-grade inflammation, insulin resistance, hyperinsulinemia and the insulin-dependent modulation of macrophage activity with a focus on adipose tissue and liver.
Fan Y, Mei J, Shen Y, Gao Y, Zhao L, Meng S J Nanobiotechnology. 2025; 23(1):148.
PMID: 40016743 PMC: 11866711. DOI: 10.1186/s12951-025-03219-y.
ACSS2 and metabolic diseases: from lipid metabolism to therapeutic target.
El-Kurjieh A, Al-Arab R, Hachem Q, Ibrahim J, Kobeissy P Lipids Health Dis. 2025; 24(1):74.
PMID: 40001058 PMC: 11853604. DOI: 10.1186/s12944-025-02491-z.
Dapagliflozin Improves High-Fat Diet-Induced Cognitive Impairment in Female Mice.
Chen X, Fan M, Xiao Z, Xiong X Brain Behav. 2025; 15(2):e70361.
PMID: 39972998 PMC: 11839776. DOI: 10.1002/brb3.70361.
Vanillic acid as a promising intervention for metabolic syndrome: Preclinical studies.
Rahbardar M, Ferns G, Ghayour Mobarhan M Iran J Basic Med Sci. 2025; 28(2):141-150.
PMID: 39850111 PMC: 11756736. DOI: 10.22038/ijbms.2024.81709.17680.
Diabetic Glycation of Human Serum Albumin Affects Its Immunogenicity.
Croes C, Chrysanthou M, Hoppenbrouwers T, Wichers H, Keijer J, Savelkoul H Biomolecules. 2025; 14(12.
PMID: 39766199 PMC: 11673269. DOI: 10.3390/biom14121492.